FDG–PET/CT improves staging and modifies radiotherapy management

September 14, 2012

The addition of FDG-positron emission tomography (PET)/computed tomography (CT) revised radiotherapy decision-making and enhanced tumor staging capabilities in patients with non-small-cell lung cancer (NSCLC), research shows.

In a study of 104 patients from a single European center, implementing FDG-PET/CT revised radiotherapy decisions in 34% of patients.